Gilead Sciences, Inc.

GILD.MX·Mexico·Healthcare
Compare
2,869.25−10.85 (−0.38%)today
At close: Oct 20, 1:02 PM CST · May be delayed up to 20 min · MXN

Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close2,880.10
Open2,861.36
Day range2,861.362,890.00
52-week range2,116.002,940.00
Off day high−0.72%
Off 52-week high−2.41%
Volume991
Avg. volume (3M)1.02K
Market cap3.56T
EPS (TTM)-47.86
Forward P/E—
P/E ratio (TTM)—
Dividend yield2.05% (58.96)
Beta (5Y)0.33
Shares outstanding1.24B
Short interest—
Earnings dateOct 29, 2026
Analyst target—
Profit margin−10.64%

Against its peers

Compare in full ›
GILD.MX LLY NVS BMY MRK BIIB
Market cap 3.56T 1.14T 292.03B 125.99B 365.88B 35.92B
P/E (TTM) — 43.1 23.2 13.6 117.7 43.2
Forward P/E — 27.2 15.7 9.3 16.0 14.8
Price/book 16.3 33.8 7.0 5.6 8.7 1.9
Dividend yield 2.05% 0.54% 3.09% 4.09% 2.29% —
1-year change +26.65% +58.00% +16.90% +38.48% +69.27% +64.57%
Today −0.38% +3.49% +2.29% +4.84% +3.25% +4.12%

The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 20 min.

Latest news

All GILD.MX news ›
Fox Business·

gilead sciences inc. - GILD

Oct 19, 2026, 9:48 AM EDT Five top-selling drugs, in some cases, are costing Americans thousands in out of pocket expenses weekly and monthly. Here's the list. Drugmakers raised prices an average of 6.6% at the start of 2022. Positive…

MarketBeat·Negative

Gilead Sciences, Inc. $GILD Stake Cut by TD Waterhouse Canada Inc.

Check Out Our Latest Report on Gilead Sciences The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 29th. Investors of record on Tuesday, September 15th were paid a dividend of $0.82 per share. This…

Financial News·Negative

Gilead’s UC Pill Hits Trial Goal, Stock Still Slips

Gilead Sciences (NASDAQ: GILD) said on 19 October 2026 that its experimental ulcerative colitis pill met the main goal of a mid-stage trial. The Gilead ulcerative colitis trial, known as SWIFT, tested emvistegrast, an oral once-daily…

From articles in the 4Search news index.

In the news

98mentions in 30 days
71with it in the headline
Positivesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 98 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.